UPDATE – Pacific Rim Cobalt Opens Shanghai Office

by GlobeNewsWire | Jun 20, 2018 | Globe Newswire

Optimistic business climate accelerates need for Asian presenceVANCOUVER, British Columbia, June 21, 2018 (GLOBE NEWSWIRE) — Pacific Rim Cobalt Corp. (CSE:BOLT) (XFRA:NXFE) (OTCQB:PCRCF) (the “Company” or “Pacific Rim Cobalt”) a resource company with assets...

Pacific Rim Cobalt Opens Shanghai Office

by GlobeNewsWire | Jun 20, 2018 | Globe Newswire

Optimistic business climate accelerates need for Asian presenceVANCOUVER, British Columbia, June 20, 2018 (GLOBE NEWSWIRE) — Pacific Rim Cobalt Corp. (CSE:BOLT) (XFRA:NXFE) (OTCQB:PCRCF) (the “Company” or “Pacific Rim Cobalt”) a resource company with assets...

New OPEN MINDS Executive Seminar On Best Practices In Marketing, Negotiating, & Contracting With Health Plans Slated To Kick Off 2018 OPEN MINDS Executive Leadership Retreat

by GlobeNewsWire | Jun 20, 2018 | Globe Newswire

Gettysburg, PA, June 20, 2018 (GLOBE NEWSWIRE) — OPEN MINDS announced the details of its upcoming executive seminar, How To Build Value-Based Payer Partnerships: An OPEN MINDS Executive Seminar On Best Practices In Marketing, Negotiating, & Contracting With...

Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering

by GlobeNewsWire | Jun 20, 2018 | Globe Newswire

BOSTON, June 20, 2018 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic disorders of obesity, today announced the pricing...

AVROBIO, Inc. Announces Pricing of Initial Public Offering

by GlobeNewsWire | Jun 20, 2018 | Globe Newswire

CAMBRIDGE, Mass., June 20, 2018 (GLOBE NEWSWIRE) — AVROBIO, Inc. (the “Company”), a Phase 2 clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose,...